Inici › Malalties pulmonars intersticials › Texas › Dallas
Assaigs clínics de Malalties pulmonars intersticials a Dallas, TX
9 estudis de Malalties pulmonars intersticials busquen participants en centres de Dallas i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
ReclutantFase 3
- Baylor University Medical Center, Dallas
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutantFase 2
- Baylor University Medical Center, Dallas
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Reclutant
- Baylor University Medical Center, Dallas
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutantEstudi observacional
- Baylor University Medical Center, Dallas
- UT Southwest Medical Center Heart and Lung Clinic, Dallas
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
ReclutantEstudi observacional
- University of Texas Southwestern, Dallas
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
ReclutantEstudi observacional
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
ReclutantFase 3
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
ReclutantFase 2
- University of Texas Southwestern Medical Center, Dallas
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
ReclutantFase 2
- aTyr Investigative Site, Dallas
Assaigs de Malalties pulmonars intersticials en altres ciutats
- New York City, NY18 estudis
- Philadelphia, PA16 estudis
- Los Angeles, CA14 estudis
- Kansas City, KS13 estudis
- Durham, NC13 estudis
- Charleston, SC13 estudis
- Chicago, IL12 estudis
- Houston, TX12 estudis
- Ann Arbor, MI11 estudis
- Aurora, CO11 estudis
- Phoenix, AZ9 estudis
- Salt Lake City, UT9 estudis
Altres estudis a Dallas
- Càncer de mama55 estudis
- Càncer de pulmó de cèl·lules no petites52 estudis
- Càncer metastàtic42 estudis
- Insuficiència cardíaca42 estudis
- Càncer (tots els tipus)37 estudis
- Càncer de pròstata36 estudis
- Càncer colorrectal33 estudis
- Obesitat30 estudis
- Càncer d'ovari28 estudis
- Càncer de bufeta27 estudis
- Càncer de pulmó27 estudis
- Càncer d'endometri24 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.